Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine Coadministered With Two Attenuated Vaccines
Clinical trial NCT05952505 · UNKNOWN
Trial details
- NCT number
- NCT05952505
- Sponsor
- Shanghai Municipal Center for Disease Control and Prevention
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-01
- Primary completion
- 2023-12-01
- Enrollment
- 540
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.